Jeffrey W. Albers's Net Worth

$65.6 Million

Estimate Recalculated Sep 18, 2024 04:39PM EST

Who is Jeffrey W. Albers?

Jeffrey W. Albers has an estimated net worth of $65.6 Million. This is based on reported shares across multiple companies, which include Blueprint Medicines Corp, Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., and Spyre Therapeutics, Inc..

SEC CIK

Jeffrey W. Albers's CIK is 0001638474

Past Insider Trading and Trends

2022 was Jeffrey W. Albers's most active year for acquiring shares with 17 total transactions. Jeffrey W. Albers's most active month to acquire stocks was the month of February. 2022 was Jeffrey W. Albers's most active year for disposing of shares, totalling 31 transactions. Jeffrey W. Albers's most active month to dispose stocks was the month of February. 2021 saw Jeffrey W. Albers paying a total of $1,098,120.00 for 269,251 shares, this is the most they've acquired in one year. In 2021 Jeffrey W. Albers cashed out on 214,986 shares for a total of $10,340,373.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Blueprint Medicines Corp (BPMC) Snapshot price: $86.43

CEO AND PRESIDENT

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.80%
-9.70K
$60.81
-$1,325,390.56
157.56K
Scheduled
Sep 9
Form 4
+1.36%
2.24K
—
—
167.26K
Jun 12
Form 4
-6.27%
-11.03K
$90.69
-$1,000,582.77
165.02K
Mar 7
Form 4
—
0
$47.20
-$2,009,977.99
176.05K
Scheduled
Mar 20
Form 4
—
0
$44.52
-$1,869,650.00
176.05K
Scheduled
Jan 25
Form 4
—
0
$57.56
-$215,100.00
176.05K
Scheduled
Dec 11
Form 4
—
0
$53.30
-$172,500.00
176.05K
Nov 30
Form 4
—
0
$34.69
-$984,640.16
176.05K
Scheduled
Nov 24
Form 4
—
0
$48.13
-$241,479.62
176.05K
Scheduled
Nov 1 - Nov 3
Form 4
—
0
$25.82
-$1,197,279.52
176.05K
Sep 27 - Sep 28
Form 4
—
0
$25.84
-$1,198,400.00
176.05K
Aug 24 - Aug 25
Form 4
+1.50%
2.6K
—
—
176.05K
Jun 21
Form 4
-5.34%
-9.79K
$45.67
-$447,273.41
173.45K
Mar 6
Form 4
—
0
$29.27
-$833,000.00
183.24K
Scheduled
Dec 5
Form 4
—
0
$42.73
-$554,433.96
183.24K
Scheduled
Aug 19 - Aug 22
Form 4
—
0
$38.42
-$1,199,453.40
183.24K
Scheduled
Aug 16
Form 4
—
0
$38.46
-$632,311.90
183.24K
Scheduled
Aug 8
Form 4
—
0
$32.17
-$949,014.64
183.24K
Scheduled
May 16
Form 4
—
0
$42.56
-$275,500.00
183.24K
Scheduled
Apr 6
Form 4
-6.48%
-12.71K
$33.99
-$1,692,061.78
183.24K
Scheduled
Mar 3 - Mar 7
Form 4
+3.98%
7.5K
—
—
195.95K
Mar 1
Form 4
—
0
$63.12
-$3,083,348.86
188.45K
Scheduled
Nov 15
Form 4
—
0
$65.08
-$500,750.00
188.45K
Scheduled
Nov 1
Form 4
+9.28%
16K
$1.87
$29,920.00
188.45K
Aug 26
Form 4
—
0
$51.88
-$2,040,402.00
172.45K
Scheduled
Aug 19
Form 4
—
0
$51.88
-$2,040,665.75
172.45K
Scheduled
May 12
Form 4
-4.95%
-8.99K
$49.04
-$1,607,006.44
172.45K
Scheduled
Mar 4
Form 4
+28.28%
40K
—
—
181.43K
Mar 1
Form 4
—
0
$63.99
-$551,900.00
141.43K
Scheduled
Dec 14
Form 4
—
0
$53.76
-$1,798,294.52
141.43K
Scheduled
Nov 16
Form 4
—
0
$53.99
-$451,850.00
141.43K
Scheduled
Oct 7
Form 4
—
0
$41.91
-$1,324,438.22
141.43K
Scheduled
Aug 19
Form 4
—
0
$36.74
-$1,117,427.24
141.43K
Scheduled
May 12
Form 4
+16.47%
20K
$28.71
-$829,076.86
141.43K
Scheduled
Mar 23
Form 4
-1.84%
-2.28K
$51.97
-$118,335.69
121.43K
Mar 9
Form 4
+57.17%
45K
—
—
123.71K
Mar 1
Form 4
—
0
$38.74
-$1,447,024.80
48.96K
Scheduled
Nov 8 - Nov 18
Form 4
+69.06%
20K
$1.87
$37,400.00
48.96K
Oct 30
Form 4
—
0
$41.80
-$1,597,261.14
28.96K
Scheduled
Aug 19
Form 4
—
0
$50.47
-$485,950.00
28.96K
Scheduled
Jun 17
Form 4
—
0
$43.31
-$1,657,506.01
28.96K
Scheduled
Jun 12
Form 4
—
0
$44.13
-$1,690,483.73
28.96K
Scheduled
Mar 15
Form 4
—
0
—
—
0
Mar 1
Form 4
∞
28.96K
$1.87
$54,157.07
28.96K
Nov 19
Form 4
—
0
$32.68
-$1,232,309.00
0
Scheduled
Nov 5
Form 4
—
0
$36.23
-$1,374,496.46
0
Scheduled
Aug 6
Form 4
—
0
$40.39
-$1,540,691.20
0
Scheduled
May 7
Form 4
—
0
$47.22
-$1,814,062.92
0
Scheduled
Mar 2
Form 4
—
0
—
—
0
Feb 16
Form 4
-100.00%
-5.49K
$36.09
-$2,063,409.77
0
Scheduled
Nov 6
Form 4
-84.54%
-30.00K
$49.62
-$1,488,636.88
5.49K
Scheduled
Aug 7 - Aug 8
Form 4
-36.05%
-20.00K
$50.47
-$1,009,393.86
35.49K
Scheduled
Jun 28
Form 4
-26.49%
-20.00K
$40.03
-$800,515.80
55.49K
Scheduled
Mar 14
Form 4
—
0
—
—
0
Feb 16
Form 4
-18.38%
-17.00K
$22.86
-$388,663.04
75.49K
Scheduled
Aug 8
Form 4
-15.53%
-17.00K
$20.03
-$340,510.00
92.49K
Scheduled
Jun 3
Form 4
-13.44%
-17.00K
$20.42
-$347,140.00
109.49K
Scheduled
Apr 6
Form 4
—
0
—
—
0
Feb 3
Form 4
-5.24%
-7.00K
$21.87
-$153,090.00
126.49K
Scheduled
Nov 10
Form 4
-6.97%
-10.00K
$21.02
-$210,200.00
133.49K
Scheduled
Nov 2
Form 3
—
0
—
—
0
No matching records found

Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$29.72
-$193,808.50
0
Aug 26
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
$24.70
-$143,557.67
0
Feb 20 - Feb 21
Form 4
—
0
$20.20
-$197,070.00
0
Jan 23
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Aug 20
Form 3
—
0
—
—
0
No matching records found

Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 7
Form 4
∞
4.15K
—
—
4.15K
Jun 25
Form 3
—
0
—
—
0
No matching records found

Spyre Therapeutics, Inc. (AGLE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 14
Form 4/A
∞
34.36K
—
—
34.36K
Nov 22 - Nov 24
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Nov 22
Form 3
—
0
—
—
0
No matching records found